These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38821597)
1. Effect of Epidermal Growth Factor Receptor Mutation on Positron Emission Tomography/Computed Tomography in Lung Cancer. Park JS; Park HY; Choi Y Anticancer Res; 2024 Jun; 44(6):2681-2687. PubMed ID: 38821597 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of multiple metabolic and heterogeneity parameters of Shi A; Wang J; Wang Y; Guo G; Fan C; Liu J Ann Nucl Med; 2022 Apr; 36(4):393-400. PubMed ID: 35084711 [TBL] [Abstract][Full Text] [Related]
3. Value of Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298 [TBL] [Abstract][Full Text] [Related]
5. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations. Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287 [TBL] [Abstract][Full Text] [Related]
6. EGFR mutation decreases FDG uptake in non‑small cell lung cancer via the NOX4/ROS/GLUT1 axis. Chen L; Zhou Y; Tang X; Yang C; Tian Y; Xie R; Chen T; Yang J; Jing M; Chen F; Wang C; Sun H; Huang Y Int J Oncol; 2019 Jan; 54(1):370-380. PubMed ID: 30431083 [TBL] [Abstract][Full Text] [Related]
7. Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma. Yanarateş A; Yazici B Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):3-8. PubMed ID: 31818695 [TBL] [Abstract][Full Text] [Related]
8. Standardized uptake value on (18)F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs. Yoshida T; Tanaka H; Kuroda H; Shimizu J; Horio Y; Sakao Y; Inaba Y; Iwata H; Hida T; Yatabe Y Lung Cancer; 2016 Oct; 100():14-19. PubMed ID: 27597275 [TBL] [Abstract][Full Text] [Related]
9. Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer. Caicedo C; Garcia-Velloso MJ; Lozano MD; Labiano T; Vigil Diaz C; Lopez-Picazo JM; Gurpide A; Zulueta JJ; Richter Echevarria JA; Perez Gracia JL Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2058-65. PubMed ID: 24990403 [TBL] [Abstract][Full Text] [Related]
10. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma]. Zhao CY; Deng XY; Wang HS; Cao GP; Ding JN; Ding CY Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):795-800. PubMed ID: 34289575 [No Abstract] [Full Text] [Related]
11. Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma. Huang CT; Yen RF; Cheng MF; Hsu YC; Wei PF; Tsai YJ; Tsai MF; Shih JY; Yang CH; Yang PC Med Oncol; 2010 Mar; 27(1):9-15. PubMed ID: 19130320 [TBL] [Abstract][Full Text] [Related]
12. An Investigation of the Relationship Between Kandemir O; Demir F Curr Radiopharm; 2024; 17(1):111-116. PubMed ID: 37644744 [TBL] [Abstract][Full Text] [Related]
13. Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma. Ko KH; Hsu HH; Huang TW; Gao HW; Shen DH; Chang WC; Hsu YC; Chang TH; Chu CM; Ho CL; Chang H Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1889-97. PubMed ID: 24852187 [TBL] [Abstract][Full Text] [Related]
14. [Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma]. Ding CY; Yang WP; Guo Z; Sun J; Li YY; Li TR Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):528-531. PubMed ID: 28728300 [No Abstract] [Full Text] [Related]
15. Correlation between EGFR mutation status and F Zhu L; Yin G; Chen W; Li X; Yu X; Zhu X; Jiang W; Jia C; Chen P; Zhang Y; Lu D; Yu L; Li X; Xu W Thorac Cancer; 2019 Apr; 10(4):659-664. PubMed ID: 30776196 [TBL] [Abstract][Full Text] [Related]
16. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer. Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer. Guan J; Xiao NJ; Chen M; Zhou WL; Zhang YW; Wang S; Dai YM; Li L; Zhang Y; Li QY; Li XZ; Yang M; Wu HB; Chen LH; Liu LY Medicine (Baltimore); 2016 Jul; 95(30):e4421. PubMed ID: 27472739 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic and predictive efficacy of Guo Y; Zhu H; Yao Z; Liu F; Yang D Eur J Radiol; 2021 Aug; 141():109792. PubMed ID: 34062472 [TBL] [Abstract][Full Text] [Related]
19. Can Du B; Wang S; Cui Y; Liu G; Li X; Li Y BMJ Open; 2021 Jun; 11(6):e044313. PubMed ID: 34103313 [TBL] [Abstract][Full Text] [Related]
20. [Semiquantitative parameters of Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]